|
SAE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69600000710091E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.59780000341669E-08 |
| Normal-vs-Stage2 |
1.055640E-02 |
| Normal-vs-Stage3 |
9.38449995491197E-09 |
| Normal-vs-Stage4 |
1.8268000445687E-09 |
| Stage1-vs-Stage2 |
2.076400E-01 |
| Stage1-vs-Stage3 |
2.973800E-01 |
| Stage1-vs-Stage4 |
7.640100E-02 |
| Stage2-vs-Stage3 |
7.813700E-02 |
| Stage2-vs-Stage4 |
2.480200E-02 |
| Stage3-vs-Stage4 |
3.657200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.04780004064986E-09 |
| Normal-vs-AfricanAmerican |
6.222300E-03 |
| Normal-vs-Asian |
2.56049999980412E-07 |
| Caucasian-vs-AfricanAmerican |
2.515000E-01 |
| Caucasian-vs-Asian |
7.490800E-01 |
| AfricanAmerican-vs-Asian |
1.517600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.14629999515526E-08 |
| Normal-vs-Female |
3.68959995888929E-09 |
| Male-vs-Female |
7.163000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.43780000314709E-08 |
| Normal-vs-Age(41-60Yrs) |
1.17080000139325E-08 |
| Normal-vs-Age(61-80Yrs) |
1.20389999969106E-07 |
| Normal-vs-Age(81-100Yrs) |
6.536200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.628400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.711800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.998800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.413600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.042000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.841800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.982300E-04 |
| Classical-VS-Follicular |
3.595400E-01 |
| Classical-VS-Other |
1.049170E-01 |
| Classical-VS-Normal |
9.13069999608496E-08 |
| Tall-VS-Follicular |
1.298900E-03 |
| Tall-VS-Other |
7.682800E-01 |
| Tall-VS-Normal |
1.17269971511291E-10 |
| Follicular-VS-Other |
1.376610E-01 |
| Follicular-VS-Normal |
5.431700E-04 |
| Other-VS-Normal |
1.219750E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.34529999995525E-06 |
| Normal-vs-N1 |
4.31876756579186E-14 |
| N0-vs-N1 |
3.75289999998696E-06 |
|
|
